Search

(GlobeNewswire) - Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today announced the strategic [...]

Townsville will be the first regional city in Australia to introduce a revolutionary new treatment for leukaemia and other blood cancers. The cutting-edge treatment for blood cancer patients will be [...]

Townsville will be the first regional city in Australia to introduce a revolutionary new treatment for leukaemia and other blood cancers. The cutting-edge treatment for blood cancer patients will be [...]

The Miles Labor Government is bringing a revolutionary new treatment of blood cancer patients to Townsville the first regional city in Australia to receive the capability. Known as CAR T-cell [...]

Nearly 9000 new cases of cancer are diagnosed in Estonia every year and about 4000 people die of cancer. Blood cancer, which includes lymphomas, myelomas and leukemias, accounts for 6-7% [...]

Thervacb: A Therapeutic Vaccine To Cure Hepatitis B Novel Therapeutic Vaccine To Cure Hepatitis Bspontaneous Resolution Of Hepatitis B Virus (Hbv) Infection Is Characterised By Neutralising Antibodies And Hbv-Specific T [...]

How do tumors react to a certain therapeutic approach? Knowing this before the start of a therapy would be of enormous value for people suffering from cancer as well as [...]

Senolytic Car T Cells As Novel Therapeutic Concept For Solid Tumors And Senescence-Associated Diseases. New Immunotherapies For Cancer And Beyondchimeric Antigen Receptor (Car) T Cells Are Genetically Engineered Immune Cells [...]

Cancer patients affected by certain advanced leukemias and lymphomas now have better access to Chimeric Antigen Receptor T-Cell (CAR-T) therapy closer to home, as the therapy becomes available in the [...]

(GlobeNewswire) - Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) cell therapies for patients with cancer, today announced [...]

Probing Cd28 As Checkpoint For T Cell Co-Stimulation In Cancer And Infection Role Of Cd28 Receptor In T-Cell Stimulationunderstanding T-Cells Regulation Is Critical For The Development Of A Broad Spectrum [...]

(GlobeNewswire) - Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, today provided a preliminary financial update and announced its 2024 corporate objectives. Barinthus Bio is a clinical-stage biopharmaceutical company developing [...]

Tracing Virus-Specific Cd8+ T Cell Clonotype Zonation And Function In Humans Objective The current Covid-19 pandemic highlights the need to gain better understanding of precise mechanisms that enable immune control [...]

(GlobeNewswire) - School-based wellness organization Brain Power Wellness recently hosted its CTL (Certified Teacher Leader) retreat from November 13th to 15th for NYC Teacher Leaders at Honors Haven. For those [...]

In the immune system, chronic infections and the defence against tumors often lead to the phenomenon of T cell exhaustion: In this process, the T lymphocytes gradually lose their function, [...]

Kite, a Gilead Company and Epicrispr Biotechnologies (Epic Bio), announced the companies have entered into a research collaboration and license agreement using Epic Bios proprietary gene regulation platform to develop [...]

Tuning Immune T Cells For Cancer Therapy Funded Under European Research Council (Erc) Eu Contribution 150 000,00 Coordinated By Stichting Radboud Universitair Medisch Centrum Netherlands Objective Adoptive cell therapy (ACT) [...]

(GlobeNewswire) - Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel T cell immunotherapeutics designed to harness the power of the immune system [...]

The Fate And Therapeutic Potential Of Human Neoantigen-Specific T Cells Cancer is a global health burden and the second leading cause of death worldwide. In recent years, the development of [...]

A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has discovered that a transcription factor, TOX2, was aberrantly increased [...]

The response of the T cells of the immune system plays an important role in combating COVID-19 as well as with regard to disease progression during infection. The immune response [...]

Six institutions from Argentina, Brazil, Haiti, Mxico, and Per will receive research grants for topics related to Tuberculosis and other opportunistic infections in advanced HIV, sexually transmitted infections, and Human [...]

New data from our multiple myeloma portfolio across targets and molecular approaches show significant progress toward our goal of transforming the treatment paradigm and improving outcomes for patients Multiple first [...]

Researchers have discovered a new population of immune cells which are critical in maintaining the immune response against chronic infections and cancer. This population of T cells also mediates the [...]

Scientists have found that Covaxin, which is an inactivated whole-virion vaccine, induces robust immune memory to SARS-CoV-2 and variants of concern that persist for at least 6 months after vaccination [...]

Boehringer Ingelheim and the Agency for Science, Technology and Research (ASTAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and [...]

Atlanta, June 3 -- Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies These engineered antibodies may allow for [...]

-- Kites Global CAR T-Cell Therapy Manufacturing Network Increasing Capacity by 50% to Meet Patient Demand for New Cancer Therapies -- Scalable and Adaptable Facility Provides Flexibility for Current and [...]

The presence of sentinel immune cells is vital to maintain and regulate the balance of the bodys immune response. Researchers have discovered an essential role of these cells in the [...]

United States based MBF THERAPEUTICS, INC. has secured contract from Iip Div Of Industrial Innovation & Partnersh for Sttr Phase I: Protective T Cell Vaccine For Sars Cov-2 (Covid-19). The [...]

AlloVir, a late-clinical stage allogeneic T-cell immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted its lead multi-virus specific T cell (VST) therapy, posoleucel (Viralym-M, [...]

Tonix Pharmaceuticals Holding Corp. (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the first participant was enrolled in a dose-finding study for TNX-2100 (SARS-CoV-2 epitope peptide mixtures [...]

QuantiFERON franchise benefits from new applications, products and automation options, building on strengths in tuberculosis detection while addressing new disease targets QuantiFERON SARS-CoV-2 assay launched in December 2021 now CE-marked [...]

Tonix Pharmaceuticals Holding Corp. (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application to [...]

INO-4800 has maintained broad T cell responses against previously known variants of concern INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people [...]

Kites Landmark CAR T-Cell Therapy Study ZUMA-7 in Relapsed/Refractory Large B-Cell Lymphoma to be Featured in ASH Plenary Session Five Oral Presentations Highlight Kites Leadership in CAR T-Cell Therapies New [...]

(GlobeNewswire) - Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat [...]

(GlobeNewswire) - Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat [...]

Boulder County, CO, is getting a new manufacturing facility, and it will come from a Seattle oncology company focused on CAR T-cell immunotherapies. Umoja Biopharma broke ground on a new [...]

(GlobeNewswire) - Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced results from preclinical in vivo studies showing production of antibodies and cytotoxic [...]

Tevogen Bio, a clinical stage biotechnology company, announced the forthcoming clinical trial of TVGN-489, its investigational allogeneic SARS-CoV-2 specific Cytotoxic CD8+ T lymphocytes (CTL) therapy for COVID-19. The study, expected [...]

Anixa Biosciences said on Monday that the US Food and Drug Administration has cleared its investigational new drug application for an autologous, follicle stimulating hormone receptor-targeting CAR T-cell product, allowing [...]

Italian startup Rigenerand is hoping to start a first-in-human clinical trial of its autologous, mesenchymal stromal cell (MSC)-based gene therapy in pancreatic cancer patients later this year, once the European [...]

Australians suffering from a rare type of blood cancer will now have access to a highly specialised CAR-T cell therapy, as the Morrison Government continues to invest in medical breakthroughs [...]

(GlobeNewswire) - Portage Biotech Inc., (NASDAQ: PRTG) (Portage or the Company) a clinical-stage immuno-oncology company focused on the development of therapies targeting cancer treatment resistance, today announced that the first [...]

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ('BioVaxys' or 'the Company') is pleased to announce that Immunologist Yvelise Barrios, MD, PhD, a specialist in Clinical Immunology at Hospital [...]

IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company advancing the development of novel cell therapies for cancer, today announced the clearance from Chinas National Medical Products Administration (NMPA) of two [...]

CAR-T cells or Chimeric antigen receptor T cells entered clinics in 2017, but since then they have already changed leukemia and lymphoma treatment. The United States Food and Drug Administration [...]

Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T cell therapies to treat solid tumors, today announced the initiation of a Phase I/II clinical trial of ECT204, a GPC3 [...]

(GlobeNewswire) - Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026 Report Highlights: Commercialization Market Potential After Market Launch: > USD 4 Billion Insight on Key Drugs [...]